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Abstract 
BACKGROUND: Ischemic stroke occurs due to the abrupt occlusion in the brain which leads to neuronal death. 
Neuronal death in ischemic stroke is due to increase production of reactive oxygen species (ROS). Neuronal 
death occurs via necrosis and apoptosis mechanisms. Apoptosis can either occur via extrinsic or intrinsic 
pathway. Meanwhile, the intrinsic pathway can be caspase-dependent or independent. Anthocyanin is a natural 
pigment with antioxidant, anti-inflammatory, anti-cancer, and neuroprotective properties. Balinese cultivate of 
purple potato extract contains a high level of anthocyanin and has been proven for its antioxidant activity.  
AIM: Antioxidant effect of Balinese cultivates purple potato extract has not been studied on an animal model with 
ischemic stroke. Accordingly, we would like to study the effect of antioxidant properties from Balinese cultivate of 
purple potato extract by assessing the neurological score, BNDF concentration, and caspase-independent 
apoptosis by measuring AIF concentration on Wistar rats with ischemic stroke. 
METHODS: This was an experimental study using male Wistar rats age between 12-14 weeks weigh between 
200 to 250 g.  
RESULTS: This study demonstrated a significant difference of neurological score on day 3 among control versus 
treatment groups. Balinese cultivate of purple potato extract markedly reduced AIF, increased BDNF, and 
suppressed apoptosis among treatment group when compared with the control group. 
CONCLUSION: We have proven the efficacy of antioxidant activity of anthocyanin derived from Balinese cultivar 
of purple sweet potato by elevated AIF levels, lower apoptosis rate, improved neurological score on day-3 to day-
7 post-stroke, as well as increased BDNF levels. 
 
 
 
 
 
 
Introduction 
 
Stroke is a degenerative disease leading to 
number one morbidity and the second cause of 
mortality worldwide. Ischemic stroke occurs due to the 
abruption of blood flow in a specific part of the brain 
which impairs neuronal homeostasis, leading to 
neuronal death. Neuronal death in ischemic stroke 
occurs due to increased production of reactive oxygen 
species (ROS) [1], [2]. Neuronal death in ischemic 
stroke occurs via either necrosis or apoptosis 
mechanism. Neuronal death can occur via extrinsic 
and intrinsic pathway. 
Furthermore, the intrinsic pathway can be 
either caspase-dependent or independent. Also, 
mitochondria play an important role in apoptosis via 
extrinsic and intrinsic mechanisms. Intrinsic 
mechanism occurs via caspase activation, i.e. the 
release of cytochrome c from mitochondria, which in 
turn binds to apoptosis platelet activating factor 
(APAF) to form apoptosome, which then facilitates 
activation of procaspase 9 into caspase 9. Afterwards, 
caspase 9 activates procaspase 3 into caspase 3 
which then becomes apoptosis executor. Also, 
mitochondria also play a role in caspase-independent 
apoptosis which releases proapoptotic proteins, 
including AIF, Diablo/Smac that triggers DNA 
fragmentation [3], [4]. 
Anthocyanin is a natural pigment that belongs 
to the flavonoid group. It exerts multiple colours to 
fruits, vegetables, and yams, while also possess 
intrinsic benefits as an antioxidant, anti-inflammation, 
anti-cancer, and neuroprotection [5], [6], [7]. 
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Balinese cultivate of purple potato extract 
contains 209.8 mg/100 g of anthocyanin [8] and has 
been proven to possess intrinsic antioxidant activity 
[9]. It also induces intrinsic antioxidant activity [10]. 
Given the account of oxidative stress as the 
underlying cause of neuronal apoptosis in ischemic 
stroke, we would like to study the effects of 
anthocyanin derived from Balinese cultivate of purple 
potato extracts against the neurological score, BDNF, 
and AIF concentration as markers for caspase-
independent apoptosis among Wistar rat with 
ischemic stroke model. 
 
 
Material and Methods 
 
The process of purple potato extraction was 
done in the Technological laboratory of farming 
products at Udayana University with the following 
described procedure. 
Purple potatoes derived from the farmer were 
then washed with sterile water, peeled for its skin, and 
subsequently sliced transversally with a thickness of 2 
to 2.5 cm. The sliced purple potato then mixed with 
sterile water with a ratio of 1 kg of purple potato to 1 L 
of water, and in turn was mixed and liquefied using a 
blender before filtered using three-layered bands. The 
obtained filtered water was heated until it boiled for 30 
minutes for sterilisation purpose. The anthocyanin 
content from this sample was 147.0 mg/mL according 
to the letter from the Technological Laboratory of 
Farming Products Udayana University no. 
145/AN/Lab/FTP/XII/2015. 
Wistar rats age between 3-3.5 months 
weighing 200 to 250 g were obtained from Biopharma 
Laboratory, Bandung. The study was conducted at the 
Bioscience Laboratory of Brawijaya University, 
Malang after had been formally permitted by the 
Ethical Committee of Brawijaya University, Malang. 
Animals were acclimatised for a week before put into 
the bite-resistant cage: twenty rats, each 10 for 
positive control and treatment group which underwent 
cerebral artery ligation without and with the 
administration of purple potato extracts, respectively. 
AIF and BDNF levels and the number of cerebral 
cortex neurons which underwent apoptosis were 
measured from 33 Wistar rats, each of which consists 
of 11 rats of the negative and positive control, and 
treatment group. Negative controls underwent neck 
skin incision and subsequently stitched, while positive 
controls underwent cerebral artery ligation without 
purple potato extracts administration, whereas the 
treatment group underwent cerebral artery ligation 
with subsequent purple potato extract administration. 
All animal models were previously anaesthetised 
using 10 mg/kg body weight of ketamine given 
intravenously via caudal vein. Ischemic stroke upon 
Wistar rats was induced by the previously described 
method [11], i.e. by ligating the right common carotid 
artery, right external carotid artery, and internal carotid 
artery on its root to the middle cerebral artery using 
silk one med soak for 2 hours. The ligation was in turn 
released after 7 days for reperfusion. Three mL of 
anthocyanin per day was administered per orally 
among the treatment group, as soon as there were 
any neurologic deficits after reperfusion. This was in 
accordance to the dose used by Jawi et al., [9] for 7 
days, only among treatment group. Neurological score 
among positive control and treatment group were 
evaluated on the first day at the first, second, and third 
hour, the third day, and the seventh day. On the 
eighth day, serum was obtained from animal models 
to evaluate BDNF and AIF levels, before decapitated 
using 10 mg per kg of body weight of ketamine using 
the caudal vein to evaluate the apoptosis. 
Neurological score was assessed by well-
trained doctoral students of the Veterinary Faculty, 
Brawijaya University. Neurological score was 
assessed by using Bederson criteria [12] as follows: 
rat was picked up by holding the distal tip of its tail 
and subsequently observed for the position of both of 
its feet. If both of their frontal feet were aligned, no 
neurological deficit was assumed. On the other hand, 
if the contralateral frontal foot from the ligated cerebral 
artery was in a flexed position, then a neurological 
deficit was assumed to occur. Rats were then put into 
a flat cover and given pressure on its back afterwards. 
Their reactions were then recorded (Table 1). 
Table 1: Neurological score 
Parameter Scale Interpretation 
Normal Level 0 No neurological deficit 
Moderate Level 1 Frontal foot flexion 
Severe Level 2 
 
Level 3 
Resistance toward lateral pressure was decreased with 
the absence of any rotation. 
Identical to level 2, accompanied by rotation. 
 
Coating microplate with protein derived from 
blood serum was done undercoating buffer for 2 hours 
on room temperature, before being washed using 
washing buffer (PBST) 3 x 3 minutes, then put into 50 
μL of 1% BSA for 1.5-hour incubation period. 
The sample was subsequently washed using 
washing buffer thrice for each for 3 minutes and 
added with 100 μL of biotin-antibody BDNF and AIF 
(rabbit anti-rat BDNF and AIF) afterwards on each 
well with subsequent incubation for 1.5-hour period on 
37°C. The samples were then washed with washing 
buffer thrice and added with TMB substrate before 
incubated for 20 minutes under room temperature and 
added NaOH. Samples were, in turn, read with ELISA 
reader on 450 nm wavelength. 
Rat brain of those had been necropsied was 
soaked in 4% paraformaldehyde solution for 1-7 days 
before being dehydrated. The tissue was mixed with 
70% alcohol thrice, and each process was left for 10 
minutes while being agitated, with subsequent mixing 
with 80%, 90%, and 95% of alcohol, and absolute 
alcohol for 10 minutes each while being agitated. 
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Samples were then added to xylol for clearing process 
which lasted overnight. Samples were then infiltrated 
by xylol paraffin and paraffin with a ratio of 1:1 for 30 
minutes. Samples were then covered with paraffin to 
form paraffin block. Liquid paraffin was subsequently 
added to the paraffin block, which then followed by 
tissue addition to the block, and waited until the 
paraffin solidified. The next step was sectioning with 5 
μm thickness. The ribbon-like tissue sections were 
then attached to the object glass which had been 
wiped with Mayer Albumin. 
The next step was deparaffination, in which 
the paraffin was eliminated using bathing the slide in 
the xylol for 10 minutes. Samples were soaked into 
absolute ethanol twice before being put into 96-90-80-
70% ethanol, respectively, each for 5 minutes, before 
rinsed with PBS pH 7.4, thrice, each for 5 minutes. 
Samples were then soaked in 3% hydrogen peroxide 
(inside DI water) for 5-10 minutes and subsequently 
rinsed with PBS pH 7.4, thrice, each for 5 minutes, 
then soaked into 5% BSA in PBS for 30 minutes on 
room temperature before finally rinsed again with PBS 
solution pH 7.4, thrice, each for 5 minutes. 
Samples were then mixed with rabbit anti-rat 
apoptosis and were incubated overnight at 4°C 
temperature. It was then rinsed again with PBS thrice, 
each for 3 minutes, and were in turn mixed with the 
secondary antibody of anti-goat IgG Biotin conjugated. 
Incubation was done for an hour under ambient 
temperature and was then rinsed using PBS, thrice, 
each for 3 minutes, and subsequently, SA-HRP (Strep 
Avidin-Horseradish Peroxidase) was added to the 
mixture for 10-20 minutes before rinsed again using 
PBS, thrice, each for 3 minutes. DAB chromogen 
substrate (3,3-diaminobenzidine tetrahydrochloride) 
was added and incubated for 5-10 minutes on 
ambient temperature and rinsed again using PBS. 
Counterstain was done using Hematoxylin for 5 
minutes on ambient temperature and subsequently 
washed with flowing water, before dried. It was then 
mounted with entellan and observed under light 
microscope BX-53 with 600 times magnification. 
Calculation method was done using Axio-vision ratio, 
of which can be seen at 
http://153.1.200.58:8080/immunoratio/. 
Normal data distribution of all research 
variables included in the study was tested. After data 
had been known to distribute normally, a mean 
difference of BDNF, AIF levels, as well as the 
difference between apoptosis rate between treatment, 
negative control, and positive control groups were 
measured and analysed by using one way ANOVA. 
Meanwhile, the neurological score was analysed in 
two phases, i.e. the first phase was to evaluate the 
mean difference of neurological score between control 
and treatment group over time (head-to-head) which 
was analysed using independent t-test. The second 
phase was to evaluate the mean difference of 
neurological score over time in one group (treatment 
and control group were analysed separately) by using 
one way ANOVA test. All data were tested under 95% 
confidence interval with a p-value of less than 0.05 
considered being significant. 
 
 
Results 
 
In the control group, there were differences of 
the neurological score between the first day (first, 
second, and third hour), second, and seventh day 
(table 2). There was no observable difference of 
neurological score between the first, second, and third 
hour in the first day (mean difference = 0). However, 
neurological score differed significantly between the 
first and third day by 1.4 (95% CI 1.11 – 1.69; p < 
0.001). Similarly, the mean neurological score day 1 
also differed significantly from day 7 by 3 (95% CI 
2.71 – 3.29; p < 0.001). This trend was also observed 
among a mean neurological score of day 3 when 
compared with day 7 which differed by 1.6 (95% CI 
1.31 – 1.89; p < 0.001) (Table 2). 
Table 2: Mean Difference and Significance of Neurological 
Score based on Timing 
Parameter Time Indicator Mean Difference P Value 95% Ci 
Control Group 
Day-1  
(1
st
 Hour) 
Day-1 
(2
nd
 Hour) 
0 1.0 -0.29 – 0.29 
Day-1 
(3
rd
 Hour) 
0 1.0 -0.29 – 0.29 
Day-3 1.4 < 0.001 1.11 – 1.69 
Day-7 3 < 0.001 2.71 – 3.29 
Day-3 Day-7 1.6 < 0.001 1.31 – 1.89 
Treatment Group 
Day-1  
(1
st
 Hour) 
Day-1 
(2
nd
 Hour) 
0 1.0 -1.06 – 1.06 
Day-1 
(3
rd
 Hour) 
0.6 0.50 -0.46 – 1.66 
Day-3 2 < 0.001 0.94 – 3.06 
Day-7 2.6 < 0.001 1.54 – 3.66 
Day-3 Day-7 0.6 0.50 -0.46 – 1.66 
 
Neurological score of the first hour vs. third 
hour on the first day did not differ significantly among 
treatment group (mean: 0.6; 95% CI 0.46-1.66; p = 
0.50). Nevertheless, neurological score of day-1 vs 
day-3 differed markedly by 2 (95% CI 0.94-3.06; p < 
0.001). Meanwhile, neurological score on day 1 also 
differed significantly when compared with day 7 by 2.6 
(95% CI 1.54-3.66; p < 0.001). Neurological score 
between day 3 and 7 also differed though statistically 
insignificant by 0.6 (95% CI -1.66-0.46; p < 0.50) 
(Table 2). 
Table 3: Mean difference and Significance of Neurological 
Score between Control and Treatment Group over time (head-
to-head) 
Parameter 
Control 
Group 
Treatment 
Group 
Mean 
difference 
95% CI P value 
1st hour score 3 2.60 0.40 -0.16 – 0.96 0.15 
2nd hour score 3 2.60 0.40 -0.16 – 0.96 0.17 
3
rd
 hour score 3 2 1 0.17 – 1.83 0.023 
Day 3 score 1.6 0.6 1 0.33 – 1.67 0.006 
Day 7 score 0 0 0 0 0 
  
Neurological score difference from day to an 
hour between control and treatment group 
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demonstrated that 1
st
-hour score on day 1 between 
control and treatment group differed by 0.4, although 
statistically insignificant (95% CI -0.16-0.96; p = 0.15). 
Whereas 2
nd
-hour score of both groups also differed 
by 0.4 but statistically insignificant (95% CI -0.16-0.96; 
p = 0.17). In contrast, neurological sore on the 3
rd
 
hour began to show gap by 1 and was statistically 
significant (95% CI 0.17-1.83; p = 0.023) (Figure 1). 
 
Figure 1: Mean neurological score difference between treatment 
and control group over time (* indicates significance, p < 0.05) 
 
Mean BDNF levels between treatment and 
positive control differed markedly by 965.45 (95% CI 
909.44 – 1,021.46; p < 0.001).  
Table 4: BDNF, AIF, and Apoptosis 
Parameter 
Reference 
Indicator 
Comparator Mean 
difference 
P value 95% CI 
BDNF 
Treatment Positive control 965.45 < 0.001 909.44 – 1,021.46 
Negative 
control 
-916.99 < 0.001 -973.00 – -860.99 
Negative control Positive control 
1.882.45 < 0.001 
1,826.44 – 
1,938.46 
AIF 
Treatment Positive control -4.02 < 0.001 -4.06 – -3.98 
Negative 
control 
2.30 < 0.001 2.26 – 2.34 
Negative control Positive control -6.32 < 0.001 -6.36 – -6.28 
Apoptosis 
Treatment Positive control -17.86 < 0.001 -26.04 – -9.69 
Negative 
control 
1.99 0.821 -6.18 – 10.16 
      
Meanwhile, average BDNF levels between 
treatment and negative control group were also found 
to differ significantly by -916.99 (95% CI -973.00 – -
860.99; p < 0.001). Mean BDNF levels between 
positive and negative control group also differed 
significantly by 1,882.45 (95% CI 1,826.44 – 1,938.46) 
[Figure 2 (left)]. 
According to the one-way ANOVA test, AIF 
levels differed markedly between negative control, 
positive control, and treatment group. The mean AIF 
levels between treatment and positive control differed 
markedly by -4.02 (95% CI -4.06 – 03.98; p < 0.001), 
while AIF levels between treatment and negative 
control group differed significantly by 2.30 (95% CI 
2.26 – 2.34; p < 0.001). In addition, mean AIF levels 
between negative and positive control group also 
differed by -6.32 (95% CI -6.36 – 6.28; p < 0.001) 
[Figure 2 (right)]. 
 
  
Figure 2: Mean difference of BDNF levels between treatment, 
negative and positive control group (* indicates significant results at 
p < 0.05) (left); Mean difference of AIF levels between treatment, 
negative and positive control group (* indicates significant results at 
p < 0.05) (right) 
 
The number of cells which underwent 
apoptosis between treatment and negative control 
group was found to differ insignificantly with mean of 
1.99 (95% CI -6.18 – 10.16; p = 0.82), whereas the 
mean apoptosis rate between treatment and control 
group was 17.86 and significant statistically (95% CI -
26.04 – -9.69; p < 0.001) (Figure 3). 
 
 
Figure 3: Mean rate of apoptosis between negative and positive 
control, and treatment group (* indicates significant results at 
p<0.05) 
 
 
Discussion 
 
Middle cerebral artery occlusion leads to the 
neurological deficit, infarction, and apoptosis which 
were regarded as important indicators for brain 
damage after ischemia [13]. Cerebral artery occlusion 
induces cerebral ischemia with subsequent 
mitochondrial damage that stimulates ROS 
production. ROS is a key factor in the underlying 
pathophysiology of ischemia, trauma, and 
degenerative disease. ROS induces macromolecular 
damage, including lipid peroxidation, protein oxidation, 
and DNA oxidation, all of which lead to cellular 
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damage and death (necrosis and apoptosis) [14]. 
Apoptosis occurs both via extrinsic and intrinsic 
pathway. The intrinsic mechanism involves 
mitochondria after receiving stimulus from Bcl-2 
protein family, BIH only protein, such as Bid, Ba, and 
Bim. Stimuli from these proteins will induce 
oligomerisation of pro-apoptotic proteins, including 
Bax and Bak. Bak oligomerisation and Bax will induce 
changes in the outer mitochondrial membrane 
permeability which in turn releases proapoptotic 
protein, including cytochrome c, endonuclease G, 
apoptosis induction factor (AIF), a second 
mitochondrial activator of caspase/direct IAP binding 
protein with low pl (Smac/diablo). Cytochrome c will 
bind to apoptosis platelet activating factor (APAF) 
which then forms apoptosome which further activates 
procaspase 9 into caspase 9, and subsequently 
activates caspase-3 as an executor caspase. AIF can 
induce caspase-independent apoptosis which 
spontaneously triggers DNA condensation and 
fragmentation [3], [4]. 
A pharmacological drug with antioxidant 
properties that can inhibit ROS production has a role 
in preventing brain tissue destruction) [15]. 
Anthocyanin belongs to polyphenolic class compound 
easily found in fruits, leaves, and vegetables. Both 
epidemiological data and clinical studies have 
confirmed anthocyanin efficacy in preventing multiple 
types of diseases. For instance, individuals who 
consume high levels of anthocyanin were linked with 
lower arterial stiffness rate [16]. Also, young women 
who consume high anthocyanin concentration also 
has a lower risk of getting a myocardial infarction [16] 
and Parkinson’s disease [17]. Anthocyanin can be 
commonly derived from purple sweet potato and 
possess a neuroprotective effect by inhibiting ASK1-
JNK/p38 and neutralise ROS, thus preventing 
apoptosis [7]. Balinese cultivar of purple sweet potato 
possesses anthocyanin and thus antioxidant and anti-
inflammatory properties [9]. Antioxidant activity will 
suppress ROS production, hence minimising 
mitochondrial damage and apoptotic cascade. This 
was proven by the significantly lower AIF levels (p < 
0.05) among the treatment group. Lower AIF levels 
also responsible for the significantly lower apoptosis 
rate among the treatment group (p < 0.05) (Figure 4). 
The lower rate of apoptosis also reduces neurological 
score among anthocyanin-treated mice (Figure 1). 
BNDF is a neurotrophic factor which plays a 
central role in the recovery phase after stroke. BDNF 
is a signal molecule which is crucial in neuronal 
adaptation and plasticity post-stroke [18]. BNDF is 
involved in neuronal viability, synaptic plasticity, 
learning, memory, and neuronal plasticity. BDNF 
treatment in animal models or rehabilitation has been 
shown to increase BDNF and improve neuronal 
recovery after injury/trauma. Neuronal improvement 
after cerebral trauma depends on BDNF levels 
because it is a critical neuroprotectant against 
cerebral ischemia which on in vivo study acts as anti 
excitotoxicity and inhibits inflammation, thus reducing 
apoptosis [19]. BDNF maintains neuronal viability via 
activating 2 surface receptors, i.e. tropomyosin-related 
kinase B (TrkB) and p75 neurotrophin (p75NTR). 
BDNF will, in turn, activates intracellular signalling 
pathway such as PI3K/Akt using TrkB receptor, which 
influences central nervous system development and 
function [20]. PI3K/Akt signalling pathway promotes 
cellular growth and viability by suppressing the 
activities of proapoptotic protein family of Bcl-2 [21]. 
Also, Yao et al., [22] found an increase of BDNF 
expression via TrkB and Akt activities, thus 
ameliorating apoptotic rate among mice models with 
focal cerebral ischemia treated with one of the 
flavonoid groups, i.e. quercetin. It is known that 
pharmacological therapy can modify the BDNF 
signalling pathway, including cAMP response-element 
binding protein (CREB) which facilitates cortical 
reorganisation and functional recovery after ischemic 
stroke [23]. We found significantly higher BDNF levels 
among treatment compared to positive control groups 
(p < 0.05), thus in line with lower apoptosis levels 
found among treatment groups and better 
neurological score on day-3 among treatment as 
opposed to control groups (p < 0.05). 
AIF is a proapoptotic protein released from 
mitochondria in the cytosolic and nucleus along with 
EndoG. Its released level is highly dependent on 
familial proapoptotic protein activity Bcl2 on 
mitochondria. Also, AIF is capable of inducing 
caspase-independent apoptosis by directly binds with 
DNA chromosome and induce chromatin 
condensation and remodelling, all of which facilitates 
DNA fragmentation by nuclease enzyme such as 
Endo G [24]. Apoptosis via mitochondria is induced by 
increased ROS production and inhibiting ROS as a 
representative of oxidative stress using antioxidant 
(such as anthocyanin in the form of cyanidin-3-O-
glucoside) has been proven to inhibit mitochondrial 
AIF release, thus ameliorate apoptosis among mice 
with focal cerebral ischemia [25]. Furthermore, AIF 
was found significantly different between negative and 
positive controls (p < 0.01). AIF levels between 
positive controls and treatment group were also found 
to be significantly different (p < 0.001). 
Apoptosis can occur via both extrinsic and 
intrinsic pathway. Apoptosis in ischemic stroke is one 
mechanism of cellular death among others, as a 
consequence of excessive ROS production which 
impairs mitochondrial outer membrane permeability, 
thus triggering Bax translocation from the cytoplasm 
to mitochondria and subsequent release of 
cytochrome c into the cytoplasm. Proapoptotic protein 
translation is governed by the proapoptotic protein 
family of Bcl-2 [26], [27]. 
Apoptosis via the intrinsic pathway consists of 
two mechanisms, i.e. caspase-dependent and 
caspase-independent. Caspase-dependent apoptosis 
occurs due to Bcl-2 proapoptotic protein family 
signalling, e.g. BH3 only, which then activates Bax 
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and Bak protein to form oligomer in the mitochondrial 
outer membrane, thus changing its permeability which 
triggers the release of proapoptotic proteins including 
AIF and Endo G to the cytoplasm which then activates 
apoptotic cascade [28]. 
Anthocyanin is capable of suppressing 
excessive ROS production, thus ameliorating ROS 
damaging effects, including the activation of apoptosis 
cascade [29], [30]. Anthocyanin derived from Balinese 
cultivar of purple sweet potato also possesses 
antioxidant properties as well as inducing endogenous 
antioxidant production [9], [10], thus limiting apoptosis 
cascade as demonstrated by lower AIF levels among 
treatment group (p < 0.05), Figure 4.  
In conclusion, anthocyanins derived from 
Balinese cultivar of purple sweet potato possesses 
antioxidant activity, thus able to inhibit ROS damaging 
effects among ischemic stroke model of Wistar rats. 
We have proven the efficacy of antioxidant activity of 
anthocyanin derived from Balinese cultivar of purple 
sweet potato by elevated AIF levels, lower apoptosis 
rate, improved neurological score on day-3 to day-7 
post-stroke, as well as increased BDNF levels. 
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